Precipio
Matthew was appointed to Interim Chief Financial Officer of Precipio, Inc. in March 2022. He served as Director of Financial Reporting and Analysis of Precipio, Inc. since joining the Company in June 2017 following its acquisition of Transgenomic Inc., where Matthew was the Director of Financial Reporting and Analysis since 2014. Matthew has over 30 years of experience in corporate finance for private and public companies.
This person is not in any teams
This person is not in any offices
Precipio
Precipio, as translated from Latin, means "to advise", and "to anticipate". We see this as the heart of our company's vision - to provide a channel to the most competent diagnostic advice, leading to the best patient care. Our goal is to offer the best...